Skip to main content
. 2005 Dec;71(12):7643–7649. doi: 10.1128/AEM.71.12.7643-7649.2005

TABLE 1.

β-Galactosidase activities of a transcriptional nprA-lacZ gene fusion in R. capsulatus B10a

Compound β-Galactosidase activity (Miller units)b
0.1 mM 0.2 mM
None 1 1
Nitrofurazone 10 30
Nitrofurantoine 18 ND
Furazolidone 9 48
CB1954 21 75
2-Aminofluorene 19 116
Benzo[a]pyrene 18 25
2,4-Dinitrotoluene 54 90
3,5-Dinitrobenzoate 52 62
2,4-Dinitrophenol 105 144
Salicylate 30 33
Paraquat ND 25
a

Cells were harvested at an A680 of about 0.5, and β-galactosidase activity was assayed as described in Materials and Methods. Cells were cultured under diazotrophic conditions with 30 mM malate as the carbon source and in the presence of different compounds at a final concentration of 0.1 mM or 0.2 mM. The compounds used were nitrofuran derivatives that are substrates of NfsA and NfsB of E. coli (27); the prodrug CB1954, which is a substrate of NfsB of E. coli (7); 2-aminofluorene and benzo[a]pyrene, substrates of SnrA of Salmonella enterica (13); several dinitroaromatics, substrates of the nitroreductase of R. capsulatus E1F1 (4); salicylate, a MarR repressor, as 2,4-dinitrophenol (2); and paraquat, a SoxR activator (9).

b

ND, not determined. The β-galactosidase activity data are means of the values obtained in three independent experiments with variations of <15%.